Bijuva Approval History
FDA Approved: Yes (First approved October 28, 2018)
Brand name: Bijuva
Generic name: estradiol and progesterone
Dosage form: Capsules
Previous Name: TX-001HR
Company: TherapeuticsMD, Inc.
Treatment for: Perimenopausal Symptoms, Postmenopausal Symptoms
Bijuva (estradiol and progesterone) is a bio-identical hormone combination for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) due to menopause.
Development History and FDA Approval Process for Bijuva
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.